Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Comparison of LanthaScreen Eu kinase binding assay and surface plasmon resonance method in elucidating the binding kinetics of focal adhesion kinase inhibitors.

Mason JL, Spais C, Husten J, Prouty E, Albom MS, Meyer SL, Ator MA, Angeles TS.

Assay Drug Dev Technol. 2012 Oct;10(5):468-75. doi: 10.1089/adt.2012.453. Epub 2012 Jun 12.

PMID:
22690705
2.

A fluorescence lifetime based binding assay to characterize kinase inhibitors.

Lebakken CS, Hee Chol Kang, Vogel KW.

J Biomol Screen. 2007 Sep;12(6):828-41. Epub 2007 Jul 20.

PMID:
17644772
3.

Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.

Lebakken CS, Riddle SM, Singh U, Frazee WJ, Eliason HC, Gao Y, Reichling LJ, Marks BD, Vogel KW.

J Biomol Screen. 2009 Sep;14(8):924-35. doi: 10.1177/1087057109339207. Epub 2009 Jun 29.

PMID:
19564447
4.

Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors.

Zaman GJ, van der Lee MM, Kok JJ, Nelissen RL, Loomans EE.

Assay Drug Dev Technol. 2006 Aug;4(4):411-20.

PMID:
16945014
5.

Kinetic studies of small molecule interactions with protein kinases using biosensor technology.

Nordin H, Jungnelius M, Karlsson R, Karlsson OP.

Anal Biochem. 2005 May 15;340(2):359-68.

PMID:
15840510
6.

Quick evaluation of kinase inhibitors by surface plasmon resonance using single-site specifically biotinylated kinases.

Kitagawa D, Gouda M, Kirii Y.

J Biomol Screen. 2014 Mar;19(3):453-61. doi: 10.1177/1087057113506051. Epub 2013 Sep 30.

PMID:
24080257
7.

Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action.

Navratilova I, Macdonald G, Robinson C, Hughes S, Mathias J, Phillips C, Cook A.

J Biomol Screen. 2012 Feb;17(2):183-93. doi: 10.1177/1087057111422746. Epub 2011 Nov 7.

PMID:
22068706
8.

Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase.

Poda SB, Kobayashi M, Nachane R, Menon V, Gandhi AS, Budac DP, Li G, Campbell BM, Tagmose L.

Assay Drug Dev Technol. 2015 Oct;13(8):466-75. doi: 10.1089/adt.2015.649. Epub 2015 Aug 20.

PMID:
26292018
9.

A combinatorial biophysical approach; FTSA and SPR for identifying small molecule ligands and PAINs.

Redhead M, Satchell R, Morkūnaitė V, Swift D, Petrauskas V, Golding E, Onions S, Matulis D, Unitt J.

Anal Biochem. 2015 Jun 15;479:63-73. doi: 10.1016/j.ab.2015.03.013. Epub 2015 Mar 30.

PMID:
25837771
10.

A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).

Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J.

J Biomol Screen. 2002 Dec;7(6):507-14.

PMID:
14599348
11.

Comparison of weak affinity chromatography and surface plasmon resonance in determining affinity of small molecules.

Duong-Thi MD, Bergström G, Mandenius CF, Bergström M, Fex T, Ohlson S.

Anal Biochem. 2014 Sep 15;461:57-9. doi: 10.1016/j.ab.2014.05.023. Epub 2014 Jun 7.

PMID:
24915639
12.

A Surface Plasmon Resonance Spectroscopy Method for Characterizing Small-Molecule Binding to Nerve Growth Factor.

Kennedy AE, Sheffield KS, Eibl JK, Murphy MB, Vohra R, Scott JA, Ross GM.

J Biomol Screen. 2016 Jan;21(1):96-100. doi: 10.1177/1087057115607814. Epub 2015 Sep 30.

PMID:
26423337
13.

Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.

Willemsen-Seegers N, Uitdehaag JC, Prinsen MB, de Vetter JR, de Man J, Sawa M, Kawase Y, Buijsman RC, Zaman GJ.

J Mol Biol. 2017 Feb 17;429(4):574-586. doi: 10.1016/j.jmb.2016.12.019. Epub 2016 Dec 30.

PMID:
28043854
14.

A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase.

Kwan J, Ling A, Papp E, Shaw D, Bradshaw JM.

Anal Biochem. 2009 Dec 15;395(2):256-62. doi: 10.1016/j.ab.2009.08.032. Epub 2009 Aug 27.

PMID:
19716360
15.
16.

Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors.

Cumming JG, Debreczeni JÉ, Edfeldt F, Evertsson E, Harrison M, Holdgate GA, James MJ, Lamont SG, Oldham K, Sullivan JE, Wells SL.

J Med Chem. 2015 Jan 8;58(1):278-93. doi: 10.1021/jm501038s. Epub 2014 Oct 9.

PMID:
25255283
17.

Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.

Sharif O, Hu H, Klock H, Hampton EN, Nigoghossian E, Knuth MW, Matzen J, Anderson P, Trager R, Uno T, Glynne RJ, Azarian SM, Caldwell JS, Brinker A.

Anal Biochem. 2009 Sep 15;392(2):162-8. doi: 10.1016/j.ab.2009.05.038. Epub 2009 May 29.

PMID:
19482004
18.

Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe.

Adachi J, Kishida M, Watanabe S, Hashimoto Y, Fukamizu K, Tomonaga T.

J Proteome Res. 2014 Dec 5;13(12):5461-70. doi: 10.1021/pr500845u. Epub 2014 Sep 30. Erratum in: J Proteome Res. 2015 Feb 6;14(2):1333.

PMID:
25230287
19.

Fragment-based discovery of focal adhesion kinase inhibitors.

Grädler U, Bomke J, Musil D, Dresing V, Lehmann M, Hölzemann G, Greiner H, Esdar C, Krier M, Heinrich T.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5401-9. doi: 10.1016/j.bmcl.2013.07.050. Epub 2013 Jul 31.

PMID:
23973211
20.

Development of surface plasmon resonance biosensor assays for primary and secondary screening of acetylcholine binding protein ligands.

Retra K, Geitmann M, Kool J, Smit AB, de Esch IJ, Danielson UH, Irth H.

Anal Biochem. 2010 Dec 1;407(1):58-64. doi: 10.1016/j.ab.2010.06.021. Epub 2010 Jun 17.

PMID:
20599657

Supplemental Content

Support Center